Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicentre phase 3 study of I10E in primary immune thrombocytopenia
2011-001354-29Phase 3Completed
- Sponsor
- LFB Group
- Start
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of subcuvia in immune thrombocytopenia (ITP), sponsored by LFB Group. Primary endpoint: Primary response rate. Started Oct 2011; status: completed.
02
Drugs
subcuvia
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on 2011-001354-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001354-29.